AHEAD is "one tool" supporting and/or tracking the Ending the HIV Epidemic in the U.S. (EHE). AHEAD helps track the six EHE indicators in areas with the highest burden of HIV. It complements and serves as one of many important implementation elements of the EHE initiative and the National HIV/AIDS...
This fact sheet discusses clinical summary of USPSTF recommendation screening for syphilis infection in nonpregnant adolescents and adults.
This fact sheet discusses the clinical summary of the USPSTF Recommendation for serologic screening for genital herpes infection.
This is an interactive map from HepVu that demonstrates overdose mortality in the United States in 2021.
This waiting room poster emphasizes that HIV testing is for everyone and that getting tested is the only way to confirm HIV status. It is intended to be used in health care settings.
This guide explains how patient assistance programs (PAPs) are run by, or in association with, pharmaceutical companies to provide free or low-cost medications to people with low incomes who generally do not qualify for any other insurance or assistance programs (such as Medicaid, Medicare, or AIDS...
This guideline discusses pharmaceutical company patience assistance and cost-sharing assistance programs for viral hepatitis.
This guideline discusses pharmaceutical company patient assistance programs and cost-sharing assistance programs for HIV treatment.
RAISE and NASTAD’s webinar, “Program Evaluation Essentials for EHE” took place on Tuesday, January 23, 2024. Dr. Roxanne Kerani discussed key evaluation methods and provided applied examples of public health HIV program evaluations.
This webpage is an online group for qualified liver specialists who are knowledgeable about chronic hepatitis B to be listed in the Hepatitis B Foundation's Physician Directory.
